| Prev Close | 159.87 |
| Day Low/High | 158.21 / 171.92 |
| 52 Wk Low/High | 36.62 / 189.26 |
Moderna, Inc. (MRNA)
170.81
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 400.18B |
| Market Cap | 63.98B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Bank Earnings, Late Day Market Surges, Vaccine Update, Trading Coinbase
Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.
Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job
You never want to be caught in a counter trend rally.
I'm Not Bailing on Johnson & Johnson Now
Don't forget, this is a very large company with a lot more than the vaccine going on.
Jim Cramer: We're Seeing the Triumph of Big Balance Sheets vs the Small Ones
I would argue that the pandemic has lasted just long enough to wipe out the little guy and let the bigger guys have the run of the joint.
I'm Buying Arcturus Therapeutics Stock and Here's the Reason Why
My COVID vaccine eligibility actually began about a week before my symptoms began.
For Now I'm Sticking With More Boring Names With Good Setups Like AT&T
A buy-write makes sense here, but the premiums are tight, so I'd rather do a buy-ratio spread.
Jim Cramer: It's Time for Clear COVID Rules That Make Sense
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
Should You Buy AstraZeneca After Its Positive Vaccine News?
Here's my view on this space and where the money is to be made.
Jim Cramer: Whenever You Think the End Is Near, Think Again
Let's look back at how the market reacted to COVID-19 one year ago, and the lessons we can learn.
Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD
COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?
Jim Cramer: Want to Put Your Stimulus Check Into Stocks? Read This First
Let's set out the case for stocks -- and which kind -- and whether you might want to pay down other debt first.
Deceptive Thursday, Rotational Roundabout, Biden Bits, Disparate Fed Data
Plus, the efficacy rate of the still-pending Novavax Covid-19 vaccine against variants of the virus give reason for pause.
Economic Stimulus, Financial Markets React, Treasury Auctions, Covid Update
How does this all end? I don't know that it does end.
What's Up at the Fed? Supply & Demand, 12 Trading Notes, Microsoft Conference
Should we care about Australia's central bank taking overtly aggressive action to reign in the long end of their yield curve? Yes, we should.
Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia
The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.
The Suppressed Economy, Impressive Earnings, U.S. Treasury Curve, Pandemic Watch
I want you to think about how quickly the long end of the U.S. Treasury curve is moving.
Jim Cramer: The Birth of a Market Bottom, Part 1
A year ago the stock market was flying high, only to plummet with the spread of a deadly, mysterious virus; this is the story of how it found a bottom.
Jim Cramer: With a Liberating Vaccine, These Are Stocks to Buy Now
As an early vaccinator I can tell you that you can make money from these strange things provided you do them before everybody gets the jab.
Here's Why I'm All in on the 'Normalization' Trade
No matter what you want to call it -- there are plenty of reasons to be bullish right now.
Jim Cramer: How Will Stocks That Thrived Amid Covid Do Post-Pandemic? Who Knows
The forces that benefited shares of companies such as Peloton Interactive and Clorox may not sustain them once the impact of the virus subsides.
There's No Reason to Give Up on Pfizer
Why? Consistency.
A Market No-Doubter, Vaccine Milestone, GDP Green Shoots, Inovio, Amazon, Google
The fact is that even if there is some compromise, the next fiscal stimulus package will be closer to $1.9 trillion than $600 billion.
Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'
Let's not kid ourselves that there is any longer some kind of relationship between price and value. Or fact and truth.
This Is Why He Is The Smartest Trader in the World
* He shoots, he scores - with NVAX (+65% or +$87/share) today Several subscribers have expressed disinterest and even snarkiness in The Smartest Trader in the World's positions -- others like to see his book on almost a daily basis. I posted this up...
Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts
Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.
Whoa Baby! Here's How I'm Trading Johnson & Johnson After Earnings
The revenue and earnings beats are nice but that's not what really got me fired up.
Could Johnson & Johnson Go Higher and Higher?
Will the vaccine will be a game changer? The charts are giving indications that J&J is ready to run.
Jim Cramer: It's High Time to Call in the Covid Assassins
Enroll the private sector that has the capability of vaccinating en masse and save the kingdom.
Moderna Now Looks Like an Effective Long Trade With Few Side Effects
MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.
Wednesday's Woe, Biden's Plan, U.S. Dollar, J&J Vaccine, Trading Intel
We are going to live again. You will dance in the aisle at some concert whose performer I have never heard of, and you will cheer for your favorite team in person again.
